NCT04434703

Brief Summary

the aim of this study is clinically and radiographically evaluate the use of advance platelet rich fibrin (A-PRF) versus platelet rich fibrin (PRF) in preservation of alveolar ridge following tooth extraction

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 17, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

November 1, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

January 29, 2021

Status Verified

January 1, 2021

Enrollment Period

8 months

First QC Date

June 13, 2020

Last Update Submit

January 28, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in bucco-lingual dimensions

    clinical measurement using bone caliper in mm numerical

    6 months

Secondary Outcomes (4)

  • change in alveolar bone height

    6 months

  • bone dentistry

    6 months

  • soft tissue healing

    6 months

  • postoperative pain scores

    2 weeks

Study Arms (3)

Platelet rich fibrin (PRF)

ACTIVE COMPARATOR

Platelet rich fibrin is the secoond generation of platelet concentrates which is an autogenous biomaterial that is prepared from the patient's own blood

Procedure: Platelet rich fibrin (PRF)

Advanced platelet rich fibrin (A-PRF)

EXPERIMENTAL

Advanced platelet rich fibrin is the last modification of PRF which is expected to contain a relatively greater number of white blood cellsand growth factors

Procedure: Advanced platelet rich fibrin (A-PRF)

blood clot

PLACEBO COMPARATOR

normal healing of the wound without adding any biomaterial

Procedure: blood clot

Interventions

following atraumatic extraction of the tooth using periotomes , 10 ml of patient's blood will be drawn by vein puncture of the antecubital vein and prepared in a centrifuge at 3000 rpm for 10 minutes then criss horizontal mattress suture will be applied to close the extraction wound

Platelet rich fibrin (PRF)

following atraumatic extraction of the tooth using periotomes , 10 ml of patient's blood will be drawn by vein puncture of the antecubital vein and prepared in a centrifuge at 1300 rpm for 8 minutes then criss horizontal mattress suture will be applied to close the extraction wound

Advanced platelet rich fibrin (A-PRF)
blood clotPROCEDURE

following atraumatic extraction of the tooth using periotomes, no bio-addative will be added and criss horizontal mattress suture will be applied to close the extraction wound

blood clot

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with at least one non restorable tooth in upper inter-bicuspid region.
  • Stable periodontal condition with no acute periapical infection.
  • Systematically healthy conditions.
  • Cooperative patients.
  • Intact buccal plate of bone.

You may not qualify if:

  • Smokers.
  • Patients seeking immediate or early implants.
  • Pregnant females.
  • Bone diseases.
  • Drugs and diseases that may affect platelet count or function.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of dentistry , Cairo University

Cairo, 11865, Egypt

Location

MeSH Terms

Interventions

Blood Coagulation

Intervention Hierarchy (Ancestors)

HemostasisBlood Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

June 13, 2020

First Posted

June 17, 2020

Study Start

November 1, 2020

Primary Completion

July 1, 2021

Study Completion

September 1, 2021

Last Updated

January 29, 2021

Record last verified: 2021-01

Locations